1. Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
   Daniel A. Ladin et al, 2016, Front. Pharmacol. CrossRef
2. Targeting cannabinoid receptors in gastrointestinal cancers for therapeutic uses: current status and future perspectives
   Ester Pagano et al, 2017, Expert Review of Gastroenterology & Hepatology CrossRef
3. Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms
   Ken Soderstrom et al, 2017, Front. Pharmacol. CrossRef
4. Synergistic interaction of the cannabinoid and death receptor systems - a potential target for future cancer therapies?
   Attila Keresztes et al, 2017, FEBS Lett CrossRef
5. Targeting the endocannabinoid system as a potential anticancer approach
   Rico Schwarz et al, 2018, Drug Metabolism Reviews CrossRef
6. The role of the lipidome in obesity-mediated colon cancer risk
   Raghav Jain et al, 2018, The Journal of Nutritional Biochemistry CrossRef
7. Metabolomic profiling suggests long chain ceramides and sphingomyelins as a possible diagnostic biomarker of epithelial ovarian cancer
   Nejc Kozar et al, 2018, Clinica Chimica Acta CrossRef
8. Insights into the effects of the endocannabinoid system in cancer: a review
   Ana Isabel Fraguas-Sánchez et al, 2018, British Journal of Pharmacology CrossRef
9. Cannabinoid pharmacology and therapy in gut disorders
   J.A. Uranga et al, 2018, Biochemical Pharmacology CrossRef
10. Strategies to target energy metabolism in consensus molecular subtype 3 along with Kirsten rat sarcoma viral oncogene homolog mutations for colorectal cancer therapy
    Gang Wang et al, 2018, J Cell Physiol CrossRef
11. Ceramides as Novel Disease Biomarkers.
    Jennifer Kurz et al, 2019, Trends Mol Med CrossRef
12. Synthetic Cannabinoid Activity Against Colorectal Cancer Cells
    Wesley M. Raup-Konsavage et al, 2018, Cannabis and Cannabinoid Research CrossRef
13. Changes in lipids composition and metabolism in colorectal cancer: a review.
    Alicja Pakiet et al, 2019, Lipids Health Dis CrossRef
14. Ceramide synthases in cancer therapy and chemoresistance
    Sebastian Brachtendorf et al, 2019, Progress in Lipid Research CrossRef
15. Body Mass Index in Multiple Sclerosis modulates ceramide-induced DNA methylation and disease course
    Kamilah Castro et al, 2019, EBioMedicine CrossRef
16. Stearoyl-CoA desaturase-1 mediated cell apoptosis in colorectal cancer by promoting ceramide synthesis
    Ling Chen et al, 2016, Sci Rep CrossRef
17. Modulation of the Endocannabinoid System as a Potential Anticancer Strategy
    Robert Ramer et al, 2019, Front. Pharmacol. CrossRef
18. Identification of Novel Predictive Biomarkers for Endometrial Malignancies: N-Acylethanolamines
    Thangesweran Ayakannu et al, 2019, Front. Oncol. CrossRef
19. Altered mRNA Expression of Genes Involved in Endocannabinoid Signalling in Squamous Cell Carcinoma of the Oral Tongue
    Mireille Alhouayek et al, 2019, Cancer Investigation CrossRef
20. Ceramide synthases in cancer therapy and chemoresistance
    Sebastian Brachtendorf et al, 2019, Progress in Lipid Research CrossRef
21. Antitumorigenic targets of cannabinoids – current status and implications
    Robert Ramer et al, 2016, Expert Opinion on Therapeutic Targets CrossRef
22. The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease
    C. Hasenoehrl et al, 2016, Neurogastroenterol. Motil. CrossRef
23. null
    Robert Ramer et al, 2017 CrossRef
24. Lipid mechanisms in hallmarks of cancer
    J. Molendijk et al, 2019, Mol. Omics CrossRef
25. Shotgun lipidomics-based characterization of the landscape of lipid metabolism in colorectal cancer
    Yuting Wang et al, 2019, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids CrossRef
26. Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer
    Ariadna Martín-Blázquez et al, 2019, Sci Rep CrossRef
27. Preferential uptake of polyunsaturated fatty acids by colorectal cancer cells
    Adriana Mika et al, 2020, Sci Rep CrossRef
28. The Endocannabinoid System: A Target for Cancer Treatment
    Chiara Laezza et al, 2020, IJMS CrossRef
29. Effects of orthotopic implantation of rat prostate tumour cells upon components of the N-acylethanolamine and monoacylglycerol signalling systems: an mRNA study
    Mireille Alhouayek et al, 2020, Sci Rep CrossRef
30. Ceramides Profile Identifies Patients with More Advanced Stages of Colorectal Cancer
    Adam R. Markowski et al, 2020, Biomolecules CrossRef
31. A conjunctive lipidomic approach reveals plasma ethanolamine plasmalogens and fatty acids as early diagnostic biomarkers for colorectal cancer patients
    Tong Liu et al, 2020, Expert Review of Proteomics CrossRef
32. Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism
    Mariona Jové et al, 2016, Oncotarget CrossRef
33. Endocannabinoid system and the expression of endogenous ceramides in human hepatocellular carcinoma
    Jiayong Yang et al, 2019, Oncol Lett CrossRef
34. Cannabinoid Effects on Experimental Colorectal Cancer Models Reduce Aberrant Crypt Foci (ACF) and Tumor Volume: A Systematic Review
    Eduardo Orrego-González et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
35. Dietary Patterns, Ceramide Ratios, and Risk of All-Cause and Cause-Specific Mortality: The Framingham Offspring Study
    Maura E Walker et al, 2020 CrossRef
36. Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis
    Andrea M. Tomko et al, 2020, Cancers CrossRef
37. Untargeted Metabolomics and Polyamine Profiling in Serum before and after Surgery in Colorectal Cancer Patients
    Yu Ra Lee et al, 2020, Metabolites CrossRef
38. Therapeutic potential of cannabinoids in combination cancer therapy
    Pratibha Malhotra et al, 2021, Advances in Biological Regulation CrossRef
39. Very long-chain fatty acids are accumulated in triacylglycerol and nonesterified forms in colorectal cancer tissues
    Kotaro Hama et al, 2021, Sci Rep CrossRef
40. Molecular Mechanism of Cannabinoids in Cancer Progression.
    Cristina Pagano et al, 2021, Int J Mol Sci CrossRef
41. Cannabinoids pharmacological effects are beyond the palliative effects: CB2 cannabinoid receptor agonist induced cytotoxicity and apoptosis in human colorectal cancer cells (HT-29).
    Aylar Alenabi et al, 2021, Mol Cell Biochem CrossRef
42. Endocannabinoid system and its modulation of brain, gut, joint and skin inflammation
    Newman Osafo et al, 2021, Mol Biol Rep CrossRef
43. The Role of Ceramide Metabolism and Signaling in the Regulation of Mitophagy and Cancer Therapy
    Megan Sheridan et al, 2021, Cancers CrossRef
44. Cannabinoids and Endocannabinoid System Changes in Intestinal Inflammation and Colorectal Cancer
    Viktoriia Cherkasova et al, 2021, Cancers CrossRef
45. The Sphingosine Kinase 2 Inhibitor ABC294640 Restores the Sensitivity of BRAFV600E Mutant Colon Cancer Cells to Vemurafenib by Reducing AKT-Mediated Expression of Nucleophosmin and Translationally-Controlled Tumour Protein
    Petra Grbčić et al, 2021, IJMS CrossRef
46. The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies
    Robert Ramer et al, 2021, Cancers CrossRef
47. Ceramide signaling in the gut
    Ying Li et al, 2022, Molecular and Cellular Endocrinology CrossRef
48. Ceramide Composition in Exosomes for Characterization of Glioblastoma Stem-Like Cell Phenotypes
    Raquel M. Melero-Fernandez de Mera et al, 2022, Front. Oncol. CrossRef
49. Ceramide-mediated gut dysbiosis enhances cholesterol esterification and promotes colorectal tumorigenesis in mice.
    Yahui Zhu et al, 2022, JCI Insight CrossRef
50. The Microbiome and Gut Endocannabinoid System in the Regulation of Stress Responses and Metabolism
    Raj Kamal Srivastava et al, 2022, Front. Cell. Neurosci. CrossRef
51. Cannabinoids, Medical Cannabis, and Colorectal Cancer Immunotherapy
    Mariia Zaiachuk et al, 2021, Front. Med. CrossRef
52. SK1 Inhibitor RB005 Induces Apoptosis in Colorectal Cancer Cells through SK1 Inhibition Dependent and Independent Pathway
    Jitendra Shrestha et al, 2022, CMP CrossRef
53. Reprogrammed Lipid Metabolism and the Lipid-Associated Hallmarks of Colorectal Cancer
    Timothy Salita et al, 2022, Cancers CrossRef
54. null
    Pedro Nuno Brandão et al, 2022 CrossRef
55. Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities
    Elliot D. Mock et al, 2022, Progress in Lipid Research CrossRef
56. Use of Cannabis and Cannabinoids for Treatment of Cancer
    Viktoriia Cherkasova et al, 2022, Cancers CrossRef
57. null
    Özge Boyacıoğlu et al, 2022 CrossRef
58. Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer
    Magdalena Grill et al, 2019, Sci Rep CrossRef
59. Venlafaxine, an anti-depressant drug, induces apoptosis in MV3 human melanoma cells through JNK1/2-Nur77 signaling pathway
    Ting Niu et al, 2023, Front. Pharmacol. CrossRef
60. Machine Learning Reveals Lipidome Remodeling Dynamics in a Mouse Model of Ovarian Cancer
    Olatomiwa O. Bifarin et al, 2023, J. Proteome Res. CrossRef
61. Diverse Sphingolipid Profiles in Rectal and Colon Cancer
    Adam R. Markowski et al, 2023, IJMS CrossRef
62. Characterization of Lipid Alterations by Oncogenic PIK3CA Mutations Using Untargeted Lipidomics in Breast Cancer
    Jae Hun Jung et al, 2023, OMICS: A Journal of Integrative Biology CrossRef
63. Hypoxia induced deregulation of sphingolipids in colon cancer is a prognostic marker for patient outcome
    Khadija El Hindi et al, 2024, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
64. Treatment of malignant diseases with phytocannabinoids: promising observations in animal models and patients
    Gerhard Nahler, 2023 CrossRef
65. Therapeutic Potential for Sphingolipids in Inflammatory Bowel Disease and Colorectal Cancer
    Keila S. Espinoza et al, 2024, Cancers CrossRef
66. How ceramides affect the development of colon cancer: from normal colon to carcinoma
    Nadine Merz et al, 2024, Pflugers Arch - Eur J Physiol CrossRef
67. Targeting Colorectal Cancer: Unravelling the Transcriptomic Impact of Cisplatin and High-THC Cannabis Extract
    Viktoriia Cherkasova et al, 2024, IJMS CrossRef
68. Endocannabinoid remodeling in murine cachexic muscle associates with catabolic and metabolic regulation
    Sebastiaan Dalle et al, 2024, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
69. The Lipid Composition of Serum-Derived Small Extracellular Vesicles in Participants of a Lung Cancer Screening Study
    Mateusz Smolarz et al, 2021, Cancers CrossRef
70. Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches
    Marta Iozzo et al, 2021, Cells CrossRef
71. Lipid biomarkers in colorectal cancer, with particular emphasis on exosomes – current status and future inferences
    Kinga Suska et al, 2024, Expert Review of Gastroenterology & Hepatology CrossRef
72. null
    Keith A. Sharkey et al, 2025 CrossRef
73. Targeting carbohydrate metabolism in colorectal cancer - synergy between DNA-damaging agents, cannabinoids, and intermittent serum starvation
    Viktoriia Cherkasova et al, 2024, Oncoscience CrossRef
74. Role of dietary and nutritional interventions in ceramide-associated diseases
    Shengnan Wang et al, 2024, Journal of Lipid Research CrossRef